Company / R&D per Share
Beam Therapeutics Inc. R&D per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$4.03
FY2025
5-year range
$4.03 / $5.66
FY2021-FY2025
Trend
-8.4%
vs FY2024
Sector context
#51 of 208
Health Care
What the data says
Beam Therapeutics Inc.'s r&d per share of $4.03 is higher than 75% of companies in the Health Care sector (FY2025). Declined from $5.36 to $4.03 over the past 2 years.
Based on SEC 10-K filings.
4.03 in FY2025 with a 5-year CAGR of -11.6%. Top quartile in the Health Care sector.
Declined from $5.36 to $4.03 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -2.7%
- 5-Year CAGR
- -11.6%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 208This company $4.03 Sector average $28.82
▼
-86.0% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 8.4% year-over-year.
- Ranks #51 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.03 | -8.4% |
| FY2024 | $4.39 | -18.0% |
| FY2023 | $5.36 | +22.6% |
| FY2022 | $4.37 | -22.8% |
| FY2021 | $5.66 | -24.1% |
| FY2020 | $7.46 | -11.6% |
| FY2019 | $8.43 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026